Benjamin Colvard, MD
Vascular Surgery · Cleveland, OHNPI 1629336680
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (34.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Penumbra, Inc. at 32.6% of the total. 2025 is the largest year on record at $9,434, 8.0 times the $1,176 reported in 2019.
Across 188 payments — averaging $156.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$10K
- Medtronic$9K
- Cook Incorporated$3K
- W. L. Gore & Associates, Inc.$2K
- Bolton Medical Inc$1K
- Cook Medical LLC$1K
- plus $3K from 25 others
Across 9 payments — averaging $944.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$9K
What the payments were for
- Speaking & faculty fees$10,20035%
- Travel & lodging$8,95831%
- Food & beverage$10,17735%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 11 | $9,569 |
| Medtronic(2 entities) | 48 | $9,162 |
| Cook Incorporated | 1 | $3,000 |
| W. L. Gore & Associates, Inc. | 19 | $2,016 |
| Bolton Medical Inc | 14 | $1,377 |
| Cook Medical LLC | 37 | $1,367 |
| Silk Road Medical, Inc. | 9 | $900 |
| Abbott | 8 | $455 |
| Surmodics, Inc. | 3 | $211 |
| Stryker | 1 | $141 |
| Inari Medical, Inc. | 1 | $125 |
| Contego Medical, Inc | 1 | $122 |
| Baxter Healthcare | 1 | $119 |
| Shockwave Medical, Inc | 4 | $107 |
| Boston Scientific | 3 | $93 |
| Cordis US CORP. | 2 | $90 |
| Johnson & Johnson | 5 | $79 |
| Argon Medical Devices, Inc. | 3 | $68 |
| Cardiovascular Systems Inc. | 2 | $42 |
| Lemaitre Vascular, Inc. | 1 | $38 |
| Novartis | 2 | $36 |
| Terumo Medical Corporation | 2 | $31 |
| Abiomed | 1 | $28 |
| Cardiva Medical, Inc. | 1 | $27 |
| Convatec Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $22 |
| Vasorum USA Inc. | 2 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $17 |
| Kaneka Medical America LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$9,357
- HawkOne$6,898
- Zenith Alpha$3,000
- GORE TAG Conformable Thoracic Endoprosthesis$822
- ENROUTE Transcarotid Neuroprotection System$754
- ENROUTE Transcarotid Stent System$644
- ENHANCE Transcarotid Peripheral Access Kit$644
- ENROUTE 0.014 Guidewire$644
- Zenith Spiral-Z$445
- Relay Grafts$402
- IN.PACT Admiral$391
- TREO ABDOMINAL STENT-GRAFT SYSTEM$324
- C3 Delivery System$270
- GORE TAG Thoracic Branch Endoprosthesis$268
- CT THROMBECTOMY SYSTEM KIT$266
- FLOWTRIEVER CATHETER, S$266
- Cook$246
- GORE VIABAHN Endoprosthesis$190
- Pounce XL Thrombectomy$187
- Pounce LP Thrombectomy$187
How this compares
$29,335 in reported general payments places this provider in the 85th percentile of 213 vascular surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 36 | $27,311 |
| EliquisApixaban | 13 | $13,501 |
| Cilostazol | 29 | $686 |
| ClopidogrelClopidogrel Bisulfate | 31 | $326 |
| Atorvastatin Calcium | 13 | $87 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $53 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $79 | $27,31136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 213 vascular surgery providers in Ohio.
Other vascular surgery in Cleveland
- Sean LydenCleveland$561K
- Federico ParodiCleveland$78K
- Francis CaputoCleveland$75K
- Levester KirkseyCleveland$57K
- Matthew EagletonCleveland$47K
- Jae ChoCleveland$34K
- Ravi AmbaniCleveland$32K
- Anthony RizzoCleveland$24K
- Daniel McLaughlinCleveland$16K
- Aric WogslandCleveland$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.